Tuesday, July 16, 2019

WuXi AppTec’s Enabling Capability Recognized by Partners and Philadelphia Authority at BIO 2019

By WuXi Content Team WuXi AppTec’s enabling capabilities and contribution to the development of life science were recognized by both its many partners and the City of Philadelphia at the BIO International Convention 2019. The BIO International Convention is hosted annually by the Biotechnology Innovation Organization...

A Breakthrough Gene Therapy Aims to Subdue Brain Cancer

Tocagen expects the results of its Phase 3 trial by the end of 2019, in which it is testing a unique form of gene therapy to produce a chemotherapeutic agent within the microenvironment of brain tumors. Crucially, this avoids the usual systemic adverse effects...

In Cancer, Boosting Chemotherapy while Reducing Toxic Side Effects is a Potential Breakthrough

GlycoMimetics is conducting a pivotal Phase 3 trial in the US, Europe and Australia to determine if its drug candidate, uproleselan, can successfully treat patients with relapsed and refractory acute myeloid leukemia (AML), a blood cancer. The unique aspect of uproleselan is that it does...

New RNA Technology Boosting Gritstone’s Immuno-therapeutics Program in Fight Against Cancer

While some life science companies are researching the new and exciting field of RNA technologies, which offer incredible advantages in drug discovery, one company, Gritstone Oncology is already applying it to its ground-breaking immunotherapy platform to fight cancer. Based in Emeryville, California, Gritstone’s goal is...

Sirnaomics Counts on New RNA Technology to Fuel Wide-Ranging Cancer & Fibrosis Pipeline

While some RNA technology companies are still exploring the accompanying science, Sirnaomics, based in Gaithersburg MD with subsidiaries in Suzhou and Guangzhou, China, has already established 10 pre-clinical and clinical RNA based programs focused on oncology and fibrosis. Two of these lines of research...

SUBSCRIBE TO OUR NEWSLETTER

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS